| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.
|
Antimicrob Agents Chemother
|
2007
|
1.94
|
|
2
|
Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.
|
J Virol
|
2007
|
1.90
|
|
3
|
Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure?
|
Clin Infect Dis
|
2012
|
1.86
|
|
4
|
Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
|
Pediatrics
|
2007
|
1.38
|
|
5
|
Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.
|
J Acquir Immune Defic Syndr
|
2010
|
1.24
|
|
6
|
Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study.
|
J Infect Dis
|
2006
|
1.16
|
|
7
|
Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.
|
Clin Infect Dis
|
2010
|
1.11
|
|
8
|
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.
|
Clin Infect Dis
|
2012
|
1.09
|
|
9
|
Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.
|
Clin Infect Dis
|
2013
|
1.05
|
|
10
|
Preventing HIV among young people: research priorities for the future.
|
J Acquir Immune Defic Syndr
|
2013
|
1.05
|
|
11
|
Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.
|
J Clin Endocrinol Metab
|
2012
|
1.04
|
|
12
|
Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.
|
Clin Infect Dis
|
2012
|
1.02
|
|
13
|
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?
|
Antimicrob Agents Chemother
|
2013
|
0.97
|
|
14
|
Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination.
|
Vaccine
|
2010
|
0.96
|
|
15
|
Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.
|
J Adolesc Health
|
2013
|
0.92
|
|
16
|
Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.
|
Hum Genet
|
2009
|
0.87
|
|
17
|
Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States.
|
Pediatr Infect Dis J
|
2010
|
0.87
|
|
18
|
Profiles of Risk Among HIV-Infected Youth in Clinic Settings.
|
AIDS Behav
|
2015
|
0.87
|
|
19
|
Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.
|
AIDS Patient Care STDS
|
2012
|
0.87
|
|
20
|
Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.
|
J Acquir Immune Defic Syndr
|
2012
|
0.85
|
|
21
|
Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.
|
AIDS Res Hum Retroviruses
|
2012
|
0.83
|
|
22
|
Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.
|
J Acquir Immune Defic Syndr
|
2015
|
0.83
|
|
23
|
Executive summary: opportunities for action and impact to address HIV and AIDS in adolescents.
|
J Acquir Immune Defic Syndr
|
2014
|
0.83
|
|
24
|
An assessment of the feasibility and acceptability of a friendship-based social network recruitment strategy to screen at-risk African American and Hispanic/Latina young women for HIV infection.
|
JAMA Pediatr
|
2013
|
0.80
|
|
25
|
Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.
|
Sex Transm Dis
|
2015
|
0.80
|
|
26
|
Comprehension of a simplified assent form in a vaccine trial for adolescents.
|
J Med Ethics
|
2013
|
0.79
|
|
27
|
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.
|
Antivir Ther
|
2014
|
0.77
|
|
28
|
Disparities in mental health care among HIV-infected youth.
|
J Int Assoc Provid AIDS Care
|
2013
|
0.76
|
|
29
|
Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
30
|
Creative and tailored strategies needed to foster researcher-community partnerships.
|
Am J Public Health
|
2008
|
0.75
|